Skip to main content
. 2017 Dec 7;8(70):114769–114786. doi: 10.18632/oncotarget.23082

Table 3. Lentiviral sequences.

Lentiviral Lentiviral sequences
Pri-miR-33b Forward:5′-GGATCCCTTTGGAGGCCCTGCATCAGGAGGGCTGGACAGCTGCTCCCGGGCCGGTGGCGGGTGTGGGGGCCGAGAGAGGCGGGCGGCCCCGCGGTGCATTGCTGTTGCATTGCACGTGTGTGAGGCGGGTGCAGTGCCTCGGCAGTGCAGCCCGGAGCCGGCCCCTGGCACCACGGGCCCCCATCCTGCCCCTCCCAGAGCTGGAGCCCTGGTGACCCCTGCCCTGCCTGCCACCCCCAGGCCGTGCAGCTGTTCCTGTGTGACCTGC-3′
Reverse:5′-GCAGGTCACACAGGAACAGCTGCACGGCCTGGGGGTGGCAGGCAGGGCAGGGGTCACAGGGCTCCAGCTCTGGGAGGGGCAGGATGGGGGCCCGTGGTGCCAGGGGCCGGCTCCGGGCTGCACTGCCGAGGCACTGCACCCGCCTCACACACGTGCAATGCAACAGCAATGCACCGCGGGGCCGCCCGCCTCTCTCGGCCCCCACACCCGCCACCGGCCCGGGAGCAGCTGTCCAGCCCTCCTGATGCAGGGCCTCCAAAGGGATCC-3′
Anti-miR-33b Forward: 5′-GTGCATTGCTGTTGCATTGC-3′
Reverse: 5′-GCAATGCAACAGCAATGCAC-3′
Anti-miR-NC Forward: 5′-TTCTCCGAACGTGTCACGT-3′
Reverse: 5′-ACGTGACACGTTCGGAGAA-3′